LCLIX
Price
$40.69
Change
+$0.27 (+0.67%)
Updated
Jul 3 closing price
Net Assets
2.35B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LCLIX vs VIVAX

Header iconLCLIX vs VIVAX Comparison
Open Charts LCLIX vs VIVAXBanner chart's image
ClearBridge Large Cap Value 1
Price$40.69
Change+$0.27 (+0.67%)
VolumeN/A
Net Assets2.35B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LCLIX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LCLIX vs. VIVAX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCLIX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. LCLIX (2.35B). VIVAX pays higher dividends than LCLIX: VIVAX (2.06) vs LCLIX (1.34). LCLIX was incepted earlier than VIVAX: LCLIX (12 years) vs VIVAX (33 years). LCLIX (0.51) is less costly to investors than VIVAX (0.17). LCLIX is a more actively managed with annual turnover of: 22.00 vs. VIVAX (9.00). LCLIX has a lower initial minimum investment than VIVAX: LCLIX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. LCLIX (-1.83). VIVAX return over 5 years is better than : 80.14 vs. LCLIX (47.11).
LCLIXVIVAXLCLIX / VIVAX
Total Expense Ratio0.510.17300%
Annual Report Gross Expense Ratio0.510.17300%
Fund Existence12 years33 years-
Gain YTD3.7476.20960%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.35B189B1%
Annual Yield % from dividends1.342.0665%
Returns for 1 year-1.8312.04-15%
Returns for 3 years24.2735.1669%
Returns for 5 years47.1180.1459%
Returns for 10 years58.64115.7451%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX36.410.36
+1.00%
Patient Opportunity C
ESAGX11.980.11
+0.93%
Ashmore Emerging Markets Equity ESG A
EMRGX7.950.07
+0.89%
Emerging Markets Equities Fund M
MSCRX11.020.04
+0.36%
Madison Small Cap R6
TIEWX15.73-0.02
-0.13%
Nuveen International Eq W